You can:
Name | Pituitary adenylate cyclase-activating polypeptide type I receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | ADCYAP1R1 |
Synonym | PACAPR1 pituitary adenylate cyclase activating polypeptide 1 receptor (1) PACAP1-R PACAP-R1 PACAP-R-1 [ Show all ] |
Disease | N/A |
Length | 468 |
Amino acid sequence | MAGVVHVSLAALLLLPMAPAMHSDCIFKKEQAMCLEKIQRANELMGFNDSSPGCPGMWDNITCWKPAHVGEMVLVSCPELFRIFNPDQVWETETIGESDFGDSNSLDLSDMGVVSRNCTEDGWSEPFPHYFDACGFDEYESETGDQDYYYLSVKALYTVGYSTSLVTLTTAMVILCRFRKLHCTRNFIHMNLFVSFMLRAISVFIKDWILYAEQDSNHCFISTVECKAVMVFFHYCVVSNYFWLFIEGLYLFTLLVETFFPERRYFYWYTIIGWGTPTVCVTVWATLRLYFDDTGCWDMNDSTALWWVIKGPVVGSIMVNFVLFIGIIVILVQKLQSPDMGGNESSIYLRLARSTLLLIPLFGIHYTVFAFSPENVSKRERLVFELGLGSFQGFVVAVLYCFLNGEVQAEIKRKWRSWKVNRYFAVDFKHRHPSLASSGVNGGTQLSILSKSSSQIRMSGLPADNLAT |
UniProt | P41586 |
Protein Data Bank | 3n94 |
GPCR-HGmod model | P41586 |
3D structure model | This structure is from PDB ID 3n94. |
BioLiP | BL0183307 |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL5399 |
IUPHAR | 370 |
DrugBank | N/A |
Name | CID 44566182 |
---|---|
Molecular formula | C204H331N63O53S |
IUPAC name | (3S)-4-[[2-[[(2S,3S)-1-[3-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-2-yl]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid |
Molecular weight | 4546.34 |
Hydrogen bond acceptor | 67 |
Hydrogen bond donor | 71 |
XlogP | -16.8 |
Synonyms | N/A |
Inchi Key | RRAVOYYAEVZOLX-NKPJTOMSSA-N |
Inchi ID | InChI=1S/C204H331N63O53S/c1-18-109(12)163(262-157(280)98-231-171(291)147(94-158(281)282)256-193(313)149(100-268)259-169(289)125(212)92-120-96-225-103-232-120)200(320)267-99-119-40-20-19-39-118(119)91-152(267)195(315)266-164(113(16)271)199(319)258-148(95-159(283)284)191(311)261-151(102-270)194(314)254-145(90-117-58-66-124(275)67-59-117)189(309)260-150(101-269)192(312)244-135(50-37-82-228-203(221)222)181(301)252-143(88-115-54-62-122(273)63-55-115)187(307)243-133(48-35-80-226-201(217)218)177(297)238-128(43-23-30-75-207)174(294)246-138(69-71-154(214)277)183(303)247-139(72-84-321-17)172(292)234-112(15)168(288)263-160(106(6)7)196(316)248-131(46-26-33-78-210)176(296)239-130(45-25-32-77-209)178(298)253-144(89-116-56-64-123(274)65-57-116)188(308)250-141(86-105(4)5)185(305)235-110(13)166(286)233-111(14)167(287)264-161(107(8)9)198(318)257-140(85-104(2)3)170(290)230-97-156(279)236-127(42-22-29-74-206)173(293)240-134(49-36-81-227-202(219)220)180(300)251-142(87-114-52-60-121(272)61-53-114)186(306)242-129(44-24-31-76-208)175(295)245-137(68-70-153(213)276)182(302)241-136(51-38-83-229-204(223)224)184(304)265-162(108(10)11)197(317)249-132(47-27-34-79-211)179(299)255-146(93-155(215)278)190(310)237-126(165(216)285)41-21-28-73-205/h19-20,39-40,52-67,96,103-113,125-152,160-164,268-275H,18,21-38,41-51,68-95,97-102,205-212H2,1-17H3,(H2,213,276)(H2,214,277)(H2,215,278)(H2,216,285)(H,225,232)(H,230,290)(H,231,291)(H,233,286)(H,234,292)(H,235,305)(H,236,279)(H,237,310)(H,238,297)(H,239,296)(H,240,293)(H,241,302)(H,242,306)(H,243,307)(H,244,312)(H,245,295)(H,246,294)(H,247,303)(H,248,316)(H,249,317)(H,250,308)(H,251,300)(H,252,301)(H,253,298)(H,254,314)(H,255,299)(H,256,313)(H,257,318)(H,258,319)(H,259,289)(H,260,309)(H,261,311)(H,262,280)(H,263,288)(H,264,287)(H,265,304)(H,266,315)(H,281,282)(H,283,284)(H4,217,218,226)(H4,219,220,227)(H4,221,222,228)(H4,223,224,229)/t109-,110-,111-,112-,113+,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152?,160-,161-,162-,163-,164-/m0/s1 |
PubChem CID | 44566182 |
ChEMBL | CHEMBL525957 |
IUPHAR | N/A |
BindingDB | 50250092 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 4010.0 nM | PMID19413310 | BindingDB,ChEMBL |
Emax | 69.6 % | PMID19413310 | ChEMBL |
IC50 | 1420.0 nM | PMID19413310 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218